US Patent Issued to Kymera Therapeutics on Aug. 25 for "Protein degraders and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,877, issued on Aug. 25, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.).

"Protein degraders and uses thereof" was invented by Nello Mainolfi (Belmont, Mass.), Nan Ji (Arlington, Mass.), Yi Zhang (Belmont, Mass.) and Matthew M. Weiss (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds, compositions thereof, and methods of using the same for the targeted degradation of proteins, and the treatment of target protein-mediated disorders."

The patent was filed on June 10, 2022, under Application No. 17/837,449.

*For further information, including images, charts and tables, please visit: http://patft...